期刊文献+

溶栓联合抗凝治疗急性次大面积肺血栓栓塞症的疗效研究 被引量:12

Effect of Thrombolysis and Anticoagulation in the Treatment of Acute Submassive Pulmonary Thromboembolism
暂未订购
导出
摘要 目的研究溶栓联合抗凝治疗急性次大面积肺血栓栓塞症的疗效。方法回顾性分析我院心内科2008年3月—2012年12月收治的急性次大面积肺血栓栓塞症患者24例,根据治疗方案的不同分为单纯抗凝组和溶栓联合抗凝组。两组患者入院后均常规给予一般处理,单纯抗凝组10例患者拒绝溶栓,故给予单纯抗凝治疗;溶栓联合抗凝组14例患者同意溶栓,采用溶栓联合抗凝治疗,均治疗10d。检测两组患者治疗前及治疗10d后PaO2和6min步行距离,并对两组患者治疗前后临床症状进行比较。结果治疗后,溶栓联合抗凝组患者PaO2和6min步行距离均高于单纯抗凝组,溶栓联合抗凝组患者呼吸困难、胸痛、发热发生率低于单纯抗凝组,差异均有统计学意义(P<0.05)。所有患者治疗后未出现重要部位出血。结论溶栓联合抗凝治疗较单纯抗凝治疗可更好地改善患者PaO2、心功能及临床症状,且不增加出血风险。 Objective To research the efficacy of thrombolysis and anticoagulation in the treatment of acute submas- sive pulmonary thromboembolism. Methods 24 patients with acute submassive pulmonary thromboembolism from March 2008 to December 2012 in our hospital were retrospectively analyzed. According to the different treatment programs, patients were divid- ed into pure anticoagulant group and thrombolysis combined with anticoagulant group. Two groups of patients were routinely given general handling after admission, the pure anticoagulant group of 10 patients refused thrombolysis, so were given anticoagulant therapy alone; The thrombolysis combined with anticoagulant group of 14 patients agreed to thrombolysis, so were given thrombol- ysis combined anticoagulant therapy, they were treated for 10d. The PaO2 and 6min walking distance of two groups were detected before and after treatment, and the occurrence of clinical manifestation of two groups were compared before and after treatment. Results After treatment, the Pa02 and 6min walking distance of thrombolysis combined with anticoagulant group were higher than those of pure anticoagulant group, the incidence of difficulty breathing, chest pain, fever of thrombolysis combined with an- ticoagulant group was lower than that of pure anticoagulant group ( P 〈 0. 05 ). All of the patients did not appeared any hemor- rhage of important position. Conclusion Compared with pure anticoagulation therapy, thrombolysis combined with anticoagulant therapy can better improve the patients' blood oxygen concentration and heart function and clinical symptom, and do not increase the risk of hemorrhage.
出处 《实用心脑肺血管病杂志》 2013年第11期36-37,40,共3页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 肺栓塞 次大面积 血栓溶解疗法 抗凝 治疗结果 Pulmonary embolism, submassive Thrombolytie therapy Anticoagulation Treatment outcome
  • 相关文献

参考文献8

二级参考文献131

  • 1荆志成,邓可武.急性肺动脉血栓栓塞症的溶栓治疗[J].中华医学杂志,2004,84(22):1932-1934. 被引量:20
  • 2邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 3Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatnlent of major pulmonary embolism. Ann Thorae Surg, 2004,77:819-823.
  • 4Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev, 2005, 19 : 179-202.
  • 5PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d' Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 2005,112:416-422.
  • 6Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients : an AAST multicenter study. J Trauma, 2007,62 : 17-24.
  • 7Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino) , 2008,49:35-49.
  • 8Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : a European nmlticenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239-245.
  • 9Dalla-Volta S, Palla A, Santolicandro A, et al. PALMS 2: aheplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 1992, 20:520-526.
  • 10Levine M, Hirsh J, Weitz J, et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest, 1990, 98: 1473-1479.

共引文献590

同被引文献83

  • 1杨学杰.老年次大面积肺栓塞采用溶栓联合抗凝疗法治疗的临床体会[J].医学信息(医学与计算机应用),2014,0(35):293-293. 被引量:3
  • 2吴晓莲.肺部疾病患者血浆D-二聚体水平的变化及意义[J].临床肺科杂志,2007,12(11):1168-1168. 被引量:22
  • 3Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population- based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study [ J ]. Arch Intern Med, 1991,151:933 - 938.
  • 4Goldhaber SZ, Kessler CM, Heit JA, et al. Recombinant tissue - type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism:a randomized controlled muhicenter trial[J]. JAm CoIl Cardiol,1992 ,20 :24 - 30.
  • 5Bray BD, Campbell J,Hoffman A,et al. Stroke thromboly- sis in England:An age stratified analysis of practice and outcome[J] Age Ageing,2012,42(2) :240-245.
  • 6Torbicki A,Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary em- bolism:The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology(ESC)[J]. Eur Heart J,2008,29(18):2276-2315.
  • 7Schoep U J, Kucher N, Kipfmueller F,et al. Right ventric- ular enlargement on chest computed tomography:A pre- dictor of early death in acute pulmonary embolism[J]. Cir- culation, 2004,110(20) : 3276-3280.
  • 8Tapson V F. Thrombolytic therapy in acute pulmonary em- bolism[J]. Curr Opin Cardiol,2012,27(6) :585-591.
  • 9Piazza G, Goldhaber SZ. Fibrinolysis for acute pulmonary embolism[J]. Vasc Med,2010,15(5) :419-428.
  • 10Wang C,Zhai ZG,Yang YH,et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: A randomized,muhicenter,controlled trial[J]. Chest,2010, 137 (2) :254-262.

引证文献12

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部